查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1710313

2025年医疗保健领域生成式人工智慧全球市场报告

Generative AI In Medicine Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年医疗保健领域生成人工智慧的市场规模将呈指数级增长。到 2029 年，这一数字将成长至 40.2 亿美元，复合年增长率为 43.5%。预测期内的成长可归因于高品质医疗资料的可用性不断增加、对预防性医疗保健的日益关注、对高效临床试验的需求不断增长、对人工智慧增强型病人参与工具的需求不断增加以及人工智慧在药物再利用中的应用日益增多。预测期内的主要趋势包括技术进步、远端医疗、个人化医疗、预测分析和穿戴式医疗技术。

预计医疗保健领域产生人工智慧 (AI) 市场的成长将受到数位健康记录成长的推动。数位健康记录或电子健康记录(EHR) 是以电子方式储存的患者健康资讯的系统集合，可促进医疗机构之间的共用并提高患者照护的效率和品质。数位医疗记录的普及是由患者照护的改善、医疗服务的效率提高、监管支持和奖励、技术进步以及患者参与度和授权的提高所推动的。医疗保健领域的人工智慧将透过自动化文件、组织资料、提供预测见解和产生个人化摘要来增强数位医疗记录，以提高准确性、可近性和整体患者照护。例如，2024 年 7 月，欧盟委员会报告称，电子健康记录的访问量从 2023 年的 72% 增加到 2024 年的 79%。因此，数位医疗记录的成长极大地推动了医疗保健市场生成性人工智慧的成长。

该市场的主要企业正专注于开发创新技术，例如用于大脑健康和保健的人工智慧解决方案，以推进认知评估、改善患者照护并加强心理健康管理。针对大脑健康和保健的人工智慧解决方案是旨在评估、监测和改善认知功能和心理健康的先进技术。例如，2024年2月，专注于人工智慧数位治疗方法的加拿大公司DiagnaMed Holdings Corp.推出了第一个针对人类心理健康和保健的人工智慧解决方案CERVAI。该解决方案利用先进的人工智慧对认知功能和大脑健康进行全面评估。它配备了尖端演算法，可以分析各种资料输入，包括认知测试和脑部影像，从而准确了解您的心理健康状况。该工具提供个人化评估和可操作的建议，有助于早期发现认知问题并采取有针对性的干预措施。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场 - 宏观经济情景，包括利率、感染疾病、地缘政治、新冠疫情、经济復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球医疗保健领域的生成人工智慧 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球医疗保健市场中的生成人工智慧：成长率分析
  • 全球医疗保健生成人工智慧市场表现：规模与成长，2019-2024
  • 全球医疗保健生成人工智慧市场预测：规模与成长，2024-2029 年，2034 年
  • 全球医疗保健领域产生人工智慧总可寻址市场 (TAM)

第六章市场区隔

  • 全球医疗保健领域生成式人工智慧市场：按组成部分、表现及预测，2019-2024 年、2024-2029 年、2034 年
  • 解决方案
  • 服务
  • 全球医疗保健领域产生人工智慧市场：按功能、效能和预测，2019-2024 年、2024-2029 年、2034 年
  • 虚拟护理助理
  • 机器人辅助AI手术
  • 优化管理流程
  • 医学影像分析
  • 全球医疗保健领域生成式人工智慧市场：应用、表现与预测（2019-2024 年、2024-2029 年及 2034 年）
  • 医学影像
  • 药物研发
  • 医疗诊断
  • 患者资料分析
  • 其他用途
  • 全球医疗保健领域生成式人工智慧市场：按最终用户、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 临床研究
  • 医疗机构
  • 诊断中心
  • 其他最终用户
  • 全球医疗保健市场生成人工智慧解决方案细分（按类型）、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 诊断工具
  • 治疗计划系统
  • 个人化医疗平台
  • 药物研发解决方案
  • 医学影像和分析软体
  • 电子健康纪录 (EHR) 丰富工具
  • 全球医疗保健市场产生人工智慧，依服务类型细分，绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 咨询服务
  • 实施和整合服务
  • 培训和教育服务
  • 技术支援和维护
  • 研发服务

第七章 区域和国家分析

  • 全球医疗保健领域生成人工智慧市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
  • 全球医疗保健领域生成人工智慧市场：按国家/地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章竞争格局与公司概况

  • 医疗保健领域的生成式人工智慧：竞争格局
  • 医疗保健市场中的生成人工智慧：公司简介
    • Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Intel Corporation Overview, Products and Services, Strategy and Financial Analysis
    • International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis
    • NVIDIA Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

  • Veeva Systems Inc.
  • Nuance Communications Inc.
  • Babylon Health Ltd.
  • Tempus Labs Inc.
  • DeepMind Technologies Limited
  • Owkin Inc.
  • Viz.ai Inc.
  • Recursion Pharmaceuticals Inc.
  • Caresyntax Inc.
  • Relay Therapeutics Inc.
  • Exscientia plc
  • Paige AI Inc.
  • BenevolentAI Limited
  • Atomwise Inc.
  • Healx Ltd.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

  • 2029年医疗保健市场中的生成式人工智慧：提供新机会的国家
  • 2029 年医疗保健领域的生成式人工智慧：提供新机会领域
  • 2029年医疗保健市场中的生成式人工智慧：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第36章 附录

简介目录
Product Code: r31892

Generative artificial intelligence (AI) in medicine involves using AI systems to create new data, models, or insights to advance healthcare and medical research. Its goal is to enhance diagnosis, treatment, and overall patient care by leveraging data-driven insights and innovative solutions.

Key components of generative AI in medicine include solutions and services. In this context, solutions refer to the advanced technologies and tools designed to improve healthcare delivery and outcomes. These solutions cover a broad range of applications, such as AI-driven diagnostic tools, virtual nursing assistants, and platforms for medical imaging analysis. Key functions include virtual nursing assistants, robot-assisted AI surgery, administrative process optimization, and medical imaging analysis. Applications span medical imaging, drug discovery, medical diagnosis, patient data analysis, and more. These technologies are utilized by various end-users, including hospitals and clinics, clinical research organizations, healthcare organizations, diagnostic centers, and others.

The generative artificial intelligence (AI) in medicine market research report is one of a series of new reports from The Business Research Company that provides generative artificial intelligence (AI) in medicine market statistics, including generative artificial intelligence (AI) in medicine industry global market size, regional shares, competitors with a generative artificial intelligence (AI) in medicine market share, detailed generative artificial intelligence (AI) in medicine market segments, market trends and opportunities, and any further data you may need to thrive in the generative artificial intelligence (AI) in medicine industry. This generative artificial intelligence (AI) in medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The generative AI in medicine market size has grown exponentially in recent years. It will grow from $0.66 $ billion in 2024 to $0.95 $ billion in 2025 at a compound annual growth rate (CAGR) of 43.9%. The growth in the historic period can be attributed to a rise in computational power and machine learning algorithms, growth in precision medicine, increasing demand for drug discovery, rise in adoption of AI for diagnostic imaging, and growth in investment in AI research and development.

The generative AI in medicine market size is expected to see exponential growth in the next few years. It will grow to $4.02 $ billion in 2029 at a compound annual growth rate (CAGR) of 43.5%. The growth in the forecast period can be attributed to the increasing availability of high-quality medical data, growing focus on preventive healthcare, growing need for efficient clinical trials, increasing demand for AI-enhanced patient engagement tools, and rising use of AI for drug repurposing. Major trends in the forecast period include technological advancements, telemedicine, personalized medicine, predictive analytics, and wearable health technology.

The growth of the generative artificial intelligence (AI) in medicine market is expected to be driven by the increase in digital health records. Digital health records, or electronic health records (EHRs), are systematic collections of patient health information stored electronically, which facilitate sharing across healthcare settings and enhance the efficiency and quality of patient care. This surge in digital health records is fueled by improvements in patient care, greater efficiency in healthcare delivery, regulatory support and incentives, technological advancements, and enhanced patient engagement and empowerment. AI in medicine enhances digital health records by automating documentation, organizing data, providing predictive insights, and generating personalized summaries to improve accuracy, accessibility, and overall patient care. For example, in July 2024, the European Commission reported that access to electronic health records increased to 79% in 2024 from 72% in 2023. Thus, the rise in digital health records is significantly driving the growth of the generative AI in medicine market.

Leading companies in this market are concentrating on developing innovative technologies, such as AI solutions for brain health and wellness, to advance cognitive assessment, improve patient care, and enhance mental health management. AI solutions for brain health and wellness are advanced technologies designed to assess, monitor, and improve cognitive function and mental well-being. For instance, in February 2024, DiagnaMed Holdings Corp., a Canada-based company specializing in AI-powered digital therapeutics, launched CERVAI, the first AI solution for human mental health and wellness. This solution utilizes advanced AI to comprehensively evaluate cognitive function and brain wellness. It features cutting-edge algorithms that analyze various data inputs, including cognitive tests and brain imaging, to provide accurate insights into mental health conditions. The tool offers personalized assessments and actionable recommendations, facilitating early detection of cognitive issues and tailored interventions.

In March 2022, Microsoft Corporation, a US-based technology company, acquired Nuance Communications Inc. for an undisclosed amount. This acquisition aims to enhance Microsoft's AI-driven, cloud-based solutions across various industries, improving customer experiences and productivity through advanced conversational AI and ambient intelligence. Nuance Communications Inc., a US-based software technology corporation, focuses on integrating generative AI into the healthcare sector.

Major companies operating in the Generative AI in medicine market are Microsoft Corporation, Intel Corporation, International Business Machines Corporation, NVIDIA Corporation, Philips Healthcare, Veeva Systems Inc., Nuance Communications Inc., Babylon Health Ltd., Tempus Labs Inc., DeepMind Technologies Limited, Owkin Inc., Viz.AI inc., Recursion Pharmaceuticals Inc., Caresyntax Inc., Relay Therapeutics Inc., Exscientia plc, Paige AI inc., BenevolentAI Limited, Atomwise Inc., Healx Ltd., Zebra Medical Vision Ltd., Eyenuk Inc., Syntegra Ltd., Arterys Inc.

North America was the largest region in the generative artificial intelligence (AI) in medicine market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the Generative AI in medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the Generative AI in medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The generative artificial intelligence (AI) in medicine market consists of revenues earned by entities providing services such as drug discovery and development, clinical trials, diagnostics, and virtual health assistants. The market value includes the value of related goods sold by the service provider or included within the service offering. The generative artificial intelligence (AI) in medicine market also includes medical imaging analysis tools, drug discovery platforms, clinical decision support systems, patient data synthesis solutions, administrative automation software, and precision medicine applications. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Generative AI In Medicine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on generative ai in medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for generative ai in medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The generative ai in medicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Component: Solutions; Service
  • 2) By Function: Virtual Nursing Assistants; Robot-Assisted AI Surgery; Administrative Process Optimization; Medical Imaging Analysis
  • 3) By Application: Medical Imaging; Drug Discovery; Medical Diagnosis; Patient Data Analysis; Other Applications
  • 4) By End-User: Hospitals And Clinics; Clinical Research; Healthcare Organizations; Diagnostic Centers; Other End-Users
  • Subsegments:
  • 1) By Solutions: Diagnostic Tools; Treatment Planning Systems; Personalized Medicine Platforms; Drug Discovery And Development Solutions; Medical Imaging And Analysis Software; Electronic Health Record (EHR) Enhancement Tools
  • 2) By Services: Consulting Services; Implementation And Integration Services; Training And Education Services; Technical Support And Maintenance; Research And Development Services.
  • Companies Mentioned: Microsoft Corporation; Intel Corporation; International Business Machines Corporation; NVIDIA Corporation; Philips Healthcare
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Generative AI In Medicine Market Characteristics

3. Generative AI In Medicine Market Trends And Strategies

4. Generative AI In Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Generative AI In Medicine Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Generative AI In Medicine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Generative AI In Medicine Market Growth Rate Analysis
  • 5.4. Global Generative AI In Medicine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Generative AI In Medicine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Generative AI In Medicine Total Addressable Market (TAM)

6. Generative AI In Medicine Market Segmentation

  • 6.1. Global Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Solutions
  • Service
  • 6.2. Global Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Virtual Nursing Assistants
  • Robot-Assisted AI Surgery
  • Administrative Process Optimization
  • Medical Imaging Analysis
  • 6.3. Global Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Medical Imaging
  • Drug Discovery
  • Medical Diagnosis
  • Patient Data Analysis
  • Other Applications
  • 6.4. Global Generative AI In Medicine Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals and Clinics
  • Clinical Research
  • Healthcare Organizations
  • Diagnostic Centers
  • Other End-Users
  • 6.5. Global Generative AI In Medicine Market, Sub-Segmentation Of Solutions, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostic Tools
  • Treatment Planning Systems
  • Personalized Medicine Platforms
  • Drug Discovery And Development Solutions
  • Medical Imaging And Analysis Software
  • Electronic Health Record (EHR) Enhancement Tools
  • 6.6. Global Generative AI In Medicine Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consulting Services
  • Implementation And Integration Services
  • Training And Education Services
  • Technical Support And Maintenance
  • Research And Development Services

7. Generative AI In Medicine Market Regional And Country Analysis

  • 7.1. Global Generative AI In Medicine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Generative AI In Medicine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Generative AI In Medicine Market

  • 8.1. Asia-Pacific Generative AI In Medicine Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Generative AI In Medicine Market

  • 9.1. China Generative AI In Medicine Market Overview
  • 9.2. China Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Generative AI In Medicine Market

  • 10.1. India Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Generative AI In Medicine Market

  • 11.1. Japan Generative AI In Medicine Market Overview
  • 11.2. Japan Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Generative AI In Medicine Market

  • 12.1. Australia Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Generative AI In Medicine Market

  • 13.1. Indonesia Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Generative AI In Medicine Market

  • 14.1. South Korea Generative AI In Medicine Market Overview
  • 14.2. South Korea Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Generative AI In Medicine Market

  • 15.1. Western Europe Generative AI In Medicine Market Overview
  • 15.2. Western Europe Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Generative AI In Medicine Market

  • 16.1. UK Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Generative AI In Medicine Market

  • 17.1. Germany Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Generative AI In Medicine Market

  • 18.1. France Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Generative AI In Medicine Market

  • 19.1. Italy Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Generative AI In Medicine Market

  • 20.1. Spain Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Generative AI In Medicine Market

  • 21.1. Eastern Europe Generative AI In Medicine Market Overview
  • 21.2. Eastern Europe Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Generative AI In Medicine Market

  • 22.1. Russia Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Generative AI In Medicine Market

  • 23.1. North America Generative AI In Medicine Market Overview
  • 23.2. North America Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Generative AI In Medicine Market

  • 24.1. USA Generative AI In Medicine Market Overview
  • 24.2. USA Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Generative AI In Medicine Market

  • 25.1. Canada Generative AI In Medicine Market Overview
  • 25.2. Canada Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Generative AI In Medicine Market

  • 26.1. South America Generative AI In Medicine Market Overview
  • 26.2. South America Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Generative AI In Medicine Market

  • 27.1. Brazil Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Generative AI In Medicine Market

  • 28.1. Middle East Generative AI In Medicine Market Overview
  • 28.2. Middle East Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Generative AI In Medicine Market

  • 29.1. Africa Generative AI In Medicine Market Overview
  • 29.2. Africa Generative AI In Medicine Market, Segmentation By Component, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Generative AI In Medicine Market, Segmentation By Function, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Generative AI In Medicine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Generative AI In Medicine Market Competitive Landscape And Company Profiles

  • 30.1. Generative AI In Medicine Market Competitive Landscape
  • 30.2. Generative AI In Medicine Market Company Profiles
    • 30.2.1. Microsoft Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Intel Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. NVIDIA Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Philips Healthcare Overview, Products and Services, Strategy and Financial Analysis

31. Generative AI In Medicine Market Other Major And Innovative Companies

  • 31.1. Veeva Systems Inc.
  • 31.2. Nuance Communications Inc.
  • 31.3. Babylon Health Ltd.
  • 31.4. Tempus Labs Inc.
  • 31.5. DeepMind Technologies Limited
  • 31.6. Owkin Inc.
  • 31.7. Viz.ai Inc.
  • 31.8. Recursion Pharmaceuticals Inc.
  • 31.9. Caresyntax Inc.
  • 31.10. Relay Therapeutics Inc.
  • 31.11. Exscientia plc
  • 31.12. Paige AI Inc.
  • 31.13. BenevolentAI Limited
  • 31.14. Atomwise Inc.
  • 31.15. Healx Ltd.

32. Global Generative AI In Medicine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Generative AI In Medicine Market

34. Recent Developments In The Generative AI In Medicine Market

35. Generative AI In Medicine Market High Potential Countries, Segments and Strategies

  • 35.1 Generative AI In Medicine Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Generative AI In Medicine Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Generative AI In Medicine Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer